Glimepiride Tablet
Product Images NDC 50268-360

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 50268-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

358 (358 15)

This is a description of Glimebiride tablets. It is a prescription medication that comes in a unit dose package of 50 tablets. The recommended dose is one tablet once a day. The available dosage is 1mg. The manufacturer warns to keep the medication out of reach of children. The manufacturer is AARE Inc, located in Pkasd TN.*

FDA Label Image

359 (359 15)

Glimepiride is a medication that comes in the form of tablets and requires a prescription. Each tablet contains 2mg of glimepiride and the package consists of 50 tablets, which are divided into five unit doses of 10 tablets each. The recommended dosage and administration instructions vary and can be found on the packaging. It is a warning that this medication should not be within the reach of children. The package contains essential information and includes a registration number. It is produced by Aare Inc. located in Plaisd, TN.*

FDA Label Image

360 (360 15)

This is a package of Glimepiride Tablets, USP, with a strength of 4mg, containing 50 tablets in total. The package has five unit doses of tablets. The recommended dosage is detailed in the packaging and it is only available under a prescription. There is a warning to keep the medication out of reach of children. The package is not for sale separately and must be kept in a cool and dry place. The product is made by AvKare.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.